CIK 0001709941
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474721157
- Phone
- +1 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Fortney Kristen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +330,000 | 330,000 | ||
| 2026-01-13 | Fortney Kristen Chief Executive Officer | Sale 10b5-1 | −233,107 | $18.12 | $4.2M | 976,949 |
| 2025-02-18 | Fortney Kristen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +530,000 | 530,000 | ||
| 2024-09-25 | Fortney Kristen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +424,827 | 424,827 | ||
| 2024-04-17 | Fortney Kristen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +708,044 | 708,044 |
Page 1 of 1 · 5 trades